BT
DXCM icon

Banque Transatlantique’s DexCom DXCM Stock Holding History

Banque Transatlantique’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$44.1K Buy
670
+380
+131% +$25.3K ﹤0.01% 372
2026
Q1 		$18.2K Sell
290
-380
-57% -$26.5K ﹤0.01% 349
2025
Q4 		$44.5K Sell
670
-300
-31% -$19.4K ﹤0.01% 167
2025
Q3 		$65.2K Sell
970
-530
-35% -$41.9K ﹤0.01% 158
2025
Q2 		$131K Hold
1,500
– – ﹤0.01% 128
2025
Q1 		$102K Hold
1,500
– – ﹤0.01% 130
2024
Q4 		$119K Buy
+1,500
New +$111K ﹤0.01% 130

Other funds holding DXCM

SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
FFM
Fisher Funds Management Auckland, New Zealand $3.52B AUM 17.59% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
FMI
Factory Mutual Insurance Waltham, Massachusetts $10.6B AUM 34.1% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Banque Transatlantique's DXCM Position: Q2 2026 in Review

Banque Transatlantique increased its DexCom (DXCM) stake by 131% in Q2 2026, buying an estimated $25.3K and bringing the position to 670 shares worth $44.1K. The position accounts for ﹤0.01% of the portfolio, ranked #372.

Banque Transatlantique first reported a position in DXCM in Q4 2024 and has held it in 7 quarters since. The position peaked at $131K in Q2 2025. 353 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Banque Transatlantique held 670 shares of DexCom worth $44.1K as of Q2 2026.
  • Banque Transatlantique bought 380 DexCom shares in Q2 2026, an estimated $25.3K.
  • DexCom made up ﹤0.01% of Banque Transatlantique's portfolio in Q2 2026, its #372 holding.
  • Banque Transatlantique first reported a position in DexCom in Q4 2024 and has held it in 7 quarters since.
  • Banque Transatlantique's DexCom position peaked at $131K in Q2 2025.
  • 353 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Banque Transatlantique's 13F filing for Q2 2026, filed 30 Jul 2026.